119 related articles for article (PubMed ID: 1126989)
1. Effect of athrombogenic therapy, especially high dose therapy of dipyridamole, after prosthetic valve replacement.
Taguchi K; Matsumura H; Washizu T; Harao M; Kato K; Kato E; Mochizuki T; Takamura K; Mashimo I; Mirifuji K; Nakagaki M; Suma T
J Cardiovasc Surg (Torino); 1975; 16(1):8-15. PubMed ID: 1126989
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease.
Ribeiro PA; Al Zaibag M; Idris M; Al Kasab S; Davies G; Mashat E; Wareham E; Al Fagih M
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):92-8. PubMed ID: 3941564
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
Sullivan JM; Harken DE; Gorlin R
N Engl J Med; 1971 Jun; 284(25):1391-4. PubMed ID: 4931099
[No Abstract] [Full Text] [Related]
4. Antiplatelet therapy in children with left-sided mechanical prostheses.
LeBlanc JG; Sett SS; Vince DJ
Eur J Cardiothorac Surg; 1993; 7(4):211-5. PubMed ID: 8481259
[TBL] [Abstract][Full Text] [Related]
5. Dipyridamole-aspirin as thromboembolic prophylaxis in patients with aortic valve prosthesis. Prospective study with the Model 2320 Starr-Edwards prosthesis.
Brott WH; Zajtchuk R; Bowen TE; Davia J; Green DC
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):632-5. PubMed ID: 7206773
[TBL] [Abstract][Full Text] [Related]
6. Late incidence and determinants of stroke after aortic and mitral valve replacement.
Ruel M; Masters RG; Rubens FD; Bédard PJ; Pipe AL; Goldstein WG; Hendry PJ; Mesana TG
Ann Thorac Surg; 2004 Jul; 78(1):77-83; discussion 83-4. PubMed ID: 15223407
[TBL] [Abstract][Full Text] [Related]
7. Use of Persantine in preventing thromboembolism following valve replacement.
Arrants JE; Hairston P
Am Surg; 1972 Aug; 38(8):432-5. PubMed ID: 5045046
[No Abstract] [Full Text] [Related]
8. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
[No Abstract] [Full Text] [Related]
9. The St. Jude Medical bileaflet valve prosthesis. A 5 year experience.
Chaux A; Czer LS; Matloff JM; DeRobertis MA; Stewart ME; Bateman TM; Kass RM; Lee ME; Gray RJ
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):706-17. PubMed ID: 6492839
[TBL] [Abstract][Full Text] [Related]
10. Experience with low-dose aspirin as thromboprophylaxis for the Tissuemed porcine aortic bioprosthesis: a survey of five years' experience.
Goldsmith I; Lip GY; Mukundan S; Rosin MD
J Heart Valve Dis; 1998 Sep; 7(5):574-9. PubMed ID: 9793859
[TBL] [Abstract][Full Text] [Related]
11. Low-dose oral anticoagulation and antiplatelet therapy with St. Jude Medical heart valve prosthesis.
Yamak B; Iscan Z; Mavitas B; Ulus AT; Katircioglu SF; Tasdemir O; Bayazit K
J Heart Valve Dis; 1999 Nov; 8(6):665-73. PubMed ID: 10616246
[TBL] [Abstract][Full Text] [Related]
12. Preliminary experience with aspirin for anticoagulation in children with prosthetic cardiac valves.
Weinstein GS; Mavroudis C; Ebert PA
Ann Thorac Surg; 1982 Jun; 33(6):549-53. PubMed ID: 6178379
[TBL] [Abstract][Full Text] [Related]
13. [Effect of prosthetic heart valve replacement on the natural course of isolated mitral and aortic as well as multivalvular diseases. Clinical results in 783 patients up to 8 years following implantation of the Björk-Shiley tilting disc prosthesis].
Horstkotte D; Loogen F; Kleikamp G; Schulte HD; Trampisch HJ; Bircks W
Z Kardiol; 1983 Sep; 72(9):494-503. PubMed ID: 6636932
[TBL] [Abstract][Full Text] [Related]
14. Platelet survival time following aortic valve replacement.
Steele P; Weily H; Davies H; Ppppas G; Genton E
Circulation; 1975 Feb; 51(2):358-62. PubMed ID: 1112016
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombo-embolism after aortic valve replacement with the Björk-Shiley tilting disc valve. Medicamental prevention with dicumarol in comparison with dipyridamole - acetylsalicylic acid. Surgical treatment of prosthetic thrombosis.
Björk VO; Henze A
Scand J Thorac Cardiovasc Surg; 1975; 9(3):183-91. PubMed ID: 54935
[TBL] [Abstract][Full Text] [Related]
16. Use of aspirin as the sole antiplatelet agent following prosthetic valve replacement in rheumatic heart disease.
John S; Bashi VV; John CN; Ravikumar E; Kumar HP; Rao S
Indian Heart J; 1994; 46(6):341-4. PubMed ID: 7797223
[TBL] [Abstract][Full Text] [Related]
17. Influence of the On-X mechanical prosthesis on intermediate-term major thromboembolism and hemorrhage: a prospective multicenter study.
Chan V; Jamieson WR; Lam BK; Ruel M; Ling H; Fradet G; Mesana TG
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1053-8.e2. PubMed ID: 20546795
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report.
Sullivan JM; Harken DE; Gorlin R
N Engl J Med; 1968 Sep; 279(11):576-80. PubMed ID: 5667468
[No Abstract] [Full Text] [Related]
19. Long-term clinical results with the Ionescu-Shiley pericardial xenograft.
Masters RG; Pipe AL; Bedard JP; Brais MP; Goldstein WG; Koshal A; Keon WJ
J Thorac Cardiovasc Surg; 1991 Jan; 101(1):81-9. PubMed ID: 1986173
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesis.
Emery RW; Krogh CC; McAdams S; Emery AM; Holter AR
J Heart Valve Dis; 2010 Jul; 19(4):473-84. PubMed ID: 20845896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
